In ex vivo human skin, no structural damage occurred in any acetyl hexapeptide‑8-FITC delivery group.
In plain wordsIn lab tests with human skin, no delivery group showed structural damage.
- Outcome
- No significant changeTissue structural damage
- Study
humann: not reported in source
human-derived facial skin- Outcome group
- Adverse events · Skin and wound
Source sentences
No structural damage was observed in any group.
3 context sentences(design, population, supporting numbers)
This study aimed to evaluate the effect of TargetCool on the permeability of Acetyl Hexapeptide-8-FITC in an ex vivo human skin model, comparing its performance alone and in combination with microneedling devices.
Facial skin samples from Korean female donors aged 50 to 70 years were prepared into 2 × 2 cm sections and assigned to 6 groups: control (topical application only), Turtle pin 0.5 mm, MTS 1.5 mm, Turtle pin 0.5 mm plus TargetCool, MTS 1.5 mm plus TargetCool, and TargetCool alone.
Samples were cultured for 24 hours in a Transwell system following treatment with Acetyl Hexapeptide-8-FITC, then processed for H&E and DAPI staining.
In this study, Argireline (acetyl hexapeptide-8) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Argireline (acetyl hexapeptide-8).